Firma InfanDx, Autor bei PR-Web

InfanDx AG Reports Successful Validation of Biomarker Panels for the Early Detection of Hypoxic Ischemic Encephalopathy

Posted on 12. October 202215. December 2023 by Firma InfanDx Posted in Research / Development Tagged aambi, apgar, banon, clinical, dynamics, elitechgroup, hie, hypoxe, infandx, ivd, mri, pathology, research, selectra, with

Numerous metabolic biomarkers identified in AAMBI study confirmed in BANON cohort Panel sensitivities of up to 89% at specificities of up to 93% in blinded validation study Formal IVD development of HypoxE® Test progressing on schedule InfanDx AG, a privately […]

Neonatal Diagnostics Company InfanDx AG Closes Oversubscribed Second Tranche of Series A

Posted on 15. March 202215. December 2023 by Firma InfanDx Posted in General Tagged aambi, biomarker, brain, clinical, cloud, expected, financial, hypoxe, infandx, medical, new, strong, supervisory, vehicle, with

Second tranche of approximately EUR 2 million additional funding raised in response to unsolicited investor interest Transaction oversubscribed by more than 50% Funding provides further financial runway and flexibility as Company progresses product development on schedule InfanDx AG, a privately-held […]

InfanDx AG: Clinical Findings from Prospective AAMBI Study Highlight Need for Better Early Detection of Neonatal Brain Injury

Posted on 10. February 202215. December 2023 by Firma InfanDx Posted in General Tagged aambi, biomarker, bonn, brain, cerebral, clinical, company, eeg, infandx, mri, research, therapy, treatment, umbilical, with

Scientific poster presented at the 13th International Newborn Brain Conference Data demonstrate the importance of novel and reliable diagnostic markers for the early detection of Hypoxic-Ischemic Encephalopathy (HIE) in newborns InfanDx AG, a privately-held diagnostics company focusing on novel solutions […]

Neonatal Diagnostics Company InfanDx Appoints Achim Plum as CEO

Posted on 4. February 202115. December 2023 by Firma InfanDx Posted in General Tagged ares, brain, cancer, cell, clinical, curetis, epigenomics, healthineers, infandx, meyer, patients, research, siemens, supervisory, with

InfanDx AG (Cologne, Germany), a privately held diagnostics company focusing on the development and commercialization of novel diagnostic solutions for newborns, today announced the appointment of Dr. Achim Plum as sole Managing Director and Chief Executive Officer (CEO). Dr. Plum […]